Results for marketing authorisation
[UPCKat] Has the UPC set too high burden to stop generic entry in Boehringer Ingelheim v Zentiva? [UPCKat] Has the UPC set too high burden to stop generic entry in Boehringer Ingelheim v Zentiva?  Reviewed by Annsley Merelle Ward on Tuesday, June 10, 2025 Rating: 5
Fordham 27 (Report 12): SPCs Fordham 27 (Report 12):  SPCs Reviewed by Annsley Merelle Ward on Tuesday, April 30, 2019 Rating: 5
Orphan Drugs, a successful regulation after all? Or just about to experience its pitfalls? Orphan Drugs, a successful regulation after all? Or just about to experience its pitfalls? Reviewed by Frantzeska Papadopoulou on Saturday, January 05, 2019 Rating: 5
EMA/Commission guidance re centralised procedure and Brexit EMA/Commission guidance re centralised procedure and Brexit Reviewed by Eibhlin Vardy on Monday, June 05, 2017 Rating: 5
Shall we dance? Regulatory approval, trade secrets and the transatlantic biosimilars patent wars Shall we dance?  Regulatory approval, trade secrets and the transatlantic biosimilars patent wars Reviewed by Annsley Merelle Ward on Sunday, March 12, 2017 Rating: 5
Does the economic impact of SPCs necessitate SPC Regulation reform? The European Commission wants to find out Does the economic impact of SPCs necessitate SPC Regulation reform?  The European Commission wants to find out  Reviewed by Annsley Merelle Ward on Thursday, January 19, 2017 Rating: 5
Powered by Blogger.